Akero Therapeutics
Price & Volume
Stats
See more52W Range | $21.34-$58.40 |
Market Cap | $3.7B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.81 |
News
See moreYahoo Finance • 6 days ago
AKERO THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Akero Therapeutics, Inc. - AKRO
Yahoo Finance • 14 days ago
AKRO Makes Notable Cross Below Critical Moving Average
Yahoo Finance • 28 days ago
Akero Therapeutics to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
About
CEO | Dr. Andrew Cheng M.D., Ph.D. |
CFO | Mr. William R. White J.D. |
Address | 601 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 67 |
